Evgeniy L. Nikonov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evgeniy L. Nikonov has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Roman O. Kuvaev
Pirogov Russian National Research Medical University
5 shared publications - Sergey V. Kashin
Yaroslavl Regional Clinical Oncology Hospital
4 shared publications A A Rudik
2 shared publications- Asiia E. Imaeva
National Medical Research Centre for Therapy and Preventive Medicine, Ministry of Health of Russia
2 shared publications - Olga Shonkorovna Oynotkinova
Research Institute For Healthcare Organization and Medical Management of Moscow Healthcare Departament
2 shared publications S A Vavrinchuk
2 shared publications
Latest Publications
- 1 October 2024
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 13 (3)
Dynamics of regional mortality from digestive diseases of different classes in Russia in 2019—2021
Objective: To assess the structure and dynamics of regional mortality in Russia associated with digestive system diseases (DSD) of different ICD classes, and their contribution to overall mortality from 2019 to 2021. Materials and Methods. Data from Rosstat on the population size in 82 regions of Russia and the number of deaths in annual age groups according to the “Short Nomenclature of Causes of Death by Rosstat” (SNCD). All causes related to DSD were selected (a — Class XI of ICD-10; b — malignant neoplasms (MN); c — infectious diseases and d — congenital anomalies and malformations). Standardized mortality rates (SMR) were calculated using software. Results. The average regional SMR associated with diseases of the four DSD groups were 124.6±28.2 per 100.000 population in 2019, 128.13±28.4 in 2020, and 127.4±29.3 in 2021. The shares of SMR from Class XI DSD and MN DSD are comparable and collectively accounted for 98.6±1.4% in 2019, 98.6±1.5% in 2020, and 98.8±1% in 2021 of all DSD. The highest SMRs are recorded for liver fibrosis/cirrhosis, and MN of the stomach and intestines. The share of deaths from non-oncological diseases, potentially requiring surgical treatment, averages 12% (maximum 38%) of the SMR of the four DSD groups. Significant variability and diverse dynamics of regional SMR values for individual DSD causes were identified, which may be partly due to multimorbidity and different approaches to determining the primary cause of death. Conclusions. An increase in the average regional SMR for the sum of the four DSD groups was noted over the three-year period. Mortality from the four DSD groups included in different ICD classes is twice as high as mortality from Class XI DSD. Methodological improvements in determining and coding causes of death from DSD are necessary.
- 1 October 2024
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 13 (3)
Dynamics of regional mortality from digestive diseases of different classes in Russia in 2019—2021
Objective: To assess the structure and dynamics of regional mortality in Russia associated with digestive system diseases (DSD) of different ICD classes, and their contribution to overall mortality from 2019 to 2021. Materials and Methods. Data from Rosstat on the population size in 82 regions of Russia and the number of deaths in annual age groups according to the “Short Nomenclature of Causes of Death by Rosstat” (SNCD). All causes related to DSD were selected (a — Class XI of ICD-10; b — malignant neoplasms (MN); c — infectious diseases and d — congenital anomalies and malformations). Standardized mortality rates (SMR) were calculated using software. Results. The average regional SMR associated with diseases of the four DSD groups were 124.6±28.2 per 100.000 population in 2019, 128.13±28.4 in 2020, and 127.4±29.3 in 2021. The shares of SMR from Class XI DSD and MN DSD are comparable and collectively accounted for 98.6±1.4% in 2019, 98.6±1.5% in 2020, and 98.8±1% in 2021 of all DSD. The highest SMRs are recorded for liver fibrosis/cirrhosis, and MN of the stomach and intestines. The share of deaths from non-oncological diseases, potentially requiring surgical treatment, averages 12% (maximum 38%) of the SMR of the four DSD groups. Significant variability and diverse dynamics of regional SMR values for individual DSD causes were identified, which may be partly due to multimorbidity and different approaches to determining the primary cause of death. Conclusions. An increase in the average regional SMR for the sum of the four DSD groups was noted over the three-year period. Mortality from the four DSD groups included in different ICD classes is twice as high as mortality from Class XI DSD. Methodological improvements in determining and coding causes of death from DSD are necessary.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 12 (2)
Principles and practical guidance for image documentation in upper gastrointestinal endoscopy
In most countries, including Russia, the mortality rate for upper gastrointestinal malignancies is comparable to its incidence rate. However, esophageal and, particularly, gastric cancer death rates are less than half of the incidence rate in Japan and South Korea. High-quality routine upper endoscopy may help reduce mortality and increase the diagnosis of precancerous lesions, early esophageal and gastric cancer, and other conditions. Endoscopy societies are implementing procedure-associated quality indicators, aiming for best practice among practitioners and evidence-based care for patients. High-quality image documentation of key anatomical landmarks can be suggested as proof of the quality of the endoscopic procedure. Beyond documentation, freezing an image offers the endoscopist the opportunity to inspect an area of interest carefully without introducing motion artifacts from the patient. Image documentation may serve as a legal record of an adequate or complete procedure. This paper offers endoscopists principles and practical guidance based on the latest international guidelines in order to carry out complete image documentation from the hypopharynx to the distal duodenum. It is noted that countries that have a higher incidence of gastric cancer have adopted an even more rigorous approach to image documentation in order to optimize early diagnosis. The wide spread of electronic image capture systems in Russian hospitals makes this an achievable goal.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 12 (2)
Principles and practical guidance for image documentation in upper gastrointestinal endoscopy
In most countries, including Russia, the mortality rate for upper gastrointestinal malignancies is comparable to its incidence rate. However, esophageal and, particularly, gastric cancer death rates are less than half of the incidence rate in Japan and South Korea. High-quality routine upper endoscopy may help reduce mortality and increase the diagnosis of precancerous lesions, early esophageal and gastric cancer, and other conditions. Endoscopy societies are implementing procedure-associated quality indicators, aiming for best practice among practitioners and evidence-based care for patients. High-quality image documentation of key anatomical landmarks can be suggested as proof of the quality of the endoscopic procedure. Beyond documentation, freezing an image offers the endoscopist the opportunity to inspect an area of interest carefully without introducing motion artifacts from the patient. Image documentation may serve as a legal record of an adequate or complete procedure. This paper offers endoscopists principles and practical guidance based on the latest international guidelines in order to carry out complete image documentation from the hypopharynx to the distal duodenum. It is noted that countries that have a higher incidence of gastric cancer have adopted an even more rigorous approach to image documentation in order to optimize early diagnosis. The wide spread of electronic image capture systems in Russian hospitals makes this an achievable goal.
- 2 February 2023
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 26 (1)
Modern algorithm of diagnostics and management of patients with chronic atrophic gastritis and intestinal metaplasia of the stomach
Эндоскопическое исследование верхних отделов пищеварительного тракта с морфологическим исследованием биоптатов слизистой оболочки желудка является важным этапом диагностики предраковой патологии желудка, начальных стадий рака желудка и отбора пациентов для последующего лечения и динамического наблюдения в рамках программы диспансеризации взрослого населения. Согласно приказу Министерства здравоохранения Российской Федерации от 27.04.21 №404н «Об утверждении Порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения», определен перечень мероприятий скрининга и методов исследований, направленных на раннее выявление онкологических заболеваний. В рамках этих мероприятий обязательным является выполнение в возрасте 45 лет эзофагогастродуоденоскопии (ЭГДС), которая при необходимости может проводиться с применением анестезиологического пособия, в том числе в медицинских организациях, оказывающих специализированную медицинскую помощь в условиях дневного стационара. Основными задачами ЭГДС являются выявление и типирование хронического гастрита, инфекции Helicobacter pylori, предопухолевой патологии желудка, оценка распространенности предопухолевых состояний слизистой оболочки и их стадирование, а также обнаружение ранних форм рака желудка и выполнение стандартизированного протокола биопсии. Однако алгоритм проведения эндоскопического исследования и биопсии, необходимость применения современных оптических технологий диагностики предопухолевых состояний слизистой оболочки и порядок наблюдения пациентов с атрофическим гастритом и предраковыми изменениями слизистой оболочки желудка не определен. Новый алгоритм эндоскопической диагностики и ведения пациентов, основанный на отечественных и международных стандартах, позволит повысить эффективность выполнения ЭГДС и наблюдения пациентов в рамках диспансеризации взрослого населения в Российской Федерации.
- 2 February 2023
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 26 (1)
Modern algorithm of diagnostics and management of patients with chronic atrophic gastritis and intestinal metaplasia of the stomach
Эндоскопическое исследование верхних отделов пищеварительного тракта с морфологическим исследованием биоптатов слизистой оболочки желудка является важным этапом диагностики предраковой патологии желудка, начальных стадий рака желудка и отбора пациентов для последующего лечения и динамического наблюдения в рамках программы диспансеризации взрослого населения. Согласно приказу Министерства здравоохранения Российской Федерации от 27.04.21 №404н «Об утверждении Порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения», определен перечень мероприятий скрининга и методов исследований, направленных на раннее выявление онкологических заболеваний. В рамках этих мероприятий обязательным является выполнение в возрасте 45 лет эзофагогастродуоденоскопии (ЭГДС), которая при необходимости может проводиться с применением анестезиологического пособия, в том числе в медицинских организациях, оказывающих специализированную медицинскую помощь в условиях дневного стационара. Основными задачами ЭГДС являются выявление и типирование хронического гастрита, инфекции Helicobacter pylori, предопухолевой патологии желудка, оценка распространенности предопухолевых состояний слизистой оболочки и их стадирование, а также обнаружение ранних форм рака желудка и выполнение стандартизированного протокола биопсии. Однако алгоритм проведения эндоскопического исследования и биопсии, необходимость применения современных оптических технологий диагностики предопухолевых состояний слизистой оболочки и порядок наблюдения пациентов с атрофическим гастритом и предраковыми изменениями слизистой оболочки желудка не определен. Новый алгоритм эндоскопической диагностики и ведения пациентов, основанный на отечественных и международных стандартах, позволит повысить эффективность выполнения ЭГДС и наблюдения пациентов в рамках диспансеризации взрослого населения в Российской Федерации.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 11 (3) , 29
New diagnostic algorithm for early detection of gastric cancer: 4D protocol
Рак желудка по-прежнему остается актуальной проблемой здравоохранения, занимает шестое место среди самых распространенных онкологических заболеваний и четвертое — среди причин смерти от них в мире. Ежегодно диагностируется более 1 млн новых случаев рака желудка. Результаты лечения рака желудка и прогноз зависят от стадии заболевания: 5-летняя выживаемость составляет 25—30%, однако этот показатель у больных ранним раком желудка (T1) после оперативного лечения достигает 95%. К сожалению, более 40% всех случаев рака желудка по-прежнему диагностируется на IV стадии. Ранний рак желудка составляет лишь 5—10% от общего числа больных с этой патологией в Европе, США и России, в то время как в Японии достигает 50%. Из всех методов диагностики эндоскопическое исследование желудка (гастроскопия) является наиболее эффективным в диагностике предопухолевой патологии и рака на ранних стадиях развития опухоли. В связи с этим вопросы совершенствования эндоскопических методик диагностики рака этой локализации, повышения качества эндоскопического исследования остаются по-прежнему в центре внимания широкого круга онкологов, гастроэнтерологов, эндоскопистов. Современная гастроскопия, проводимая с целью диагностики предраковых изменений и ранних форм рака, предполагает использование всех современных технологий, позволяющих выявлять патологические образования даже самых небольших размеров: увеличительной эндоскопии, хромоскопии и узкоспектральной эндоскопии. Наиболее эффективное и рациональное сочетание этих диагностических методик с целью визуализации очаговых структурных изменений слизистой оболочки желудка возможно при использовании современного диагностического алгоритма в повседневной клинической практике. Совершенствование последнего путем включения в него новых диагностических технологий, позволяющих провести эффективную дифференциальную диагностику неопластических изменений, создаст условия для повышения эффективности диагностики предраковых изменений слизистой оболочки и раннего рака желудка у пациентов, подлежащих скринингу.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Evidence-Based Gastroenterology
- Vol. 11 (3) , 29
New diagnostic algorithm for early detection of gastric cancer: 4D protocol
Рак желудка по-прежнему остается актуальной проблемой здравоохранения, занимает шестое место среди самых распространенных онкологических заболеваний и четвертое — среди причин смерти от них в мире. Ежегодно диагностируется более 1 млн новых случаев рака желудка. Результаты лечения рака желудка и прогноз зависят от стадии заболевания: 5-летняя выживаемость составляет 25—30%, однако этот показатель у больных ранним раком желудка (T1) после оперативного лечения достигает 95%. К сожалению, более 40% всех случаев рака желудка по-прежнему диагностируется на IV стадии. Ранний рак желудка составляет лишь 5—10% от общего числа больных с этой патологией в Европе, США и России, в то время как в Японии достигает 50%. Из всех методов диагностики эндоскопическое исследование желудка (гастроскопия) является наиболее эффективным в диагностике предопухолевой патологии и рака на ранних стадиях развития опухоли. В связи с этим вопросы совершенствования эндоскопических методик диагностики рака этой локализации, повышения качества эндоскопического исследования остаются по-прежнему в центре внимания широкого круга онкологов, гастроэнтерологов, эндоскопистов. Современная гастроскопия, проводимая с целью диагностики предраковых изменений и ранних форм рака, предполагает использование всех современных технологий, позволяющих выявлять патологические образования даже самых небольших размеров: увеличительной эндоскопии, хромоскопии и узкоспектральной эндоскопии. Наиболее эффективное и рациональное сочетание этих диагностических методик с целью визуализации очаговых структурных изменений слизистой оболочки желудка возможно при использовании современного диагностического алгоритма в повседневной клинической практике. Совершенствование последнего путем включения в него новых диагностических технологий, позволяющих провести эффективную дифференциальную диагностику неопластических изменений, создаст условия для повышения эффективности диагностики предраковых изменений слизистой оболочки и раннего рака желудка у пациентов, подлежащих скринингу.
- Open Access
- 13 August 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (8) , 496-501
Helicobacter pylori infection: place of serological and cultural diagnostics in clinical guidelines
The purpose of this work was to familiarize doctors with the methods and significance of serological and cultural diagnostics of H. pylori infection on the example of the test for diagnosing the state of the gastric mucosa «Gastropanel». Blood serum tests were performed for 1057 patients and 122 healthy people aged 18-64 years: pepsinogen I (PG I), pepsinogen II (PG II), gastrin-17 (G-17), basal/stimulated), antibodies (IgGHp) to H. pylori (Biohit Oyj, Finland). The medians of the studied group indicators did not exceed the reference intervals. 398 (34%) patients have negative H. pylori status (IgGHp-). 275 (26%) patients with serum PG I≤70 mcg/ml were identified. The ratio of PG I/II≤3 in 84 (8%), 36 of them (43% of the group PG I/II≤3) - IgGHp-.
- 13 August 2021
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 66 (8) , 496-501
Open AccessHelicobacter pylori infection: place of serological and cultural diagnostics in clinical guidelines
The purpose of this work was to familiarize doctors with the methods and significance of serological and cultural diagnostics of H. pylori infection on the example of the test for diagnosing the state of the gastric mucosa «Gastropanel». Blood serum tests were performed for 1057 patients and 122 healthy people aged 18-64 years: pepsinogen I (PG I), pepsinogen II (PG II), gastrin-17 (G-17), basal/stimulated), antibodies (IgGHp) to H. pylori (Biohit Oyj, Finland). The medians of the studied group indicators did not exceed the reference intervals. 398 (34%) patients have negative H. pylori status (IgGHp-). 275 (26%) patients with serum PG I≤70 mcg/ml were identified. The ratio of PG I/II≤3 in 84 (8%), 36 of them (43% of the group PG I/II≤3) - IgGHp-.
- Open Access
- 14 November 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5) , 2670
Age and sex characteristics of behavioral risk factors and adherence to a healthy lifestyle in Muscovites
Возрастные и гендерные характеристики поведенческих факторов риска и приверженности здоровому образу жизни у москвичей
- 14 November 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (5) , 2670
Open AccessAge and sex characteristics of behavioral risk factors and adherence to a healthy lifestyle in Muscovites
Возрастные и гендерные характеристики поведенческих факторов риска и приверженности здоровому образу жизни у москвичей
- Open Access
- 22 October 2020
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 9 (3) , 427-433
The Actual Epidemiological Effectiveness of Assessing and Improving the System for Ensuring the Epidemiological Safety of Medical Care for Catheterized Patients
The basis of optimized conventional system of surveillance and control for catheter-related bloodstream infections (CRBI) was priority in detection and risk assessment an infectious complication of puncture catheterization that substantially justified with inclusion of two main components as an addition to the existing system: monitoring of puncture catheterization, which allows to obtain and analyze data on risk factors for infections associated with the catheterization procedure and subsequent manipulations of the device, standardize approaches to working with a venous catheter and improve the diagnosis of CRBI; assessment of ensuring the epidemiological safety of medical care for catheterized patients. Epidemiological efficiency risk-based surveillance, primarily determined to reduce the incidence of CRBI by 1.8 times compared to initially defined real incidence: 12.5‰ (95% CI — CI 11,8–13 2) vs 22.8‰ (95% CI 21,1–24,5) catheterized patients, p=0.0001.
- 22 October 2020
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 9 (3) , 427-433
Open AccessThe Actual Epidemiological Effectiveness of Assessing and Improving the System for Ensuring the Epidemiological Safety of Medical Care for Catheterized Patients
The basis of optimized conventional system of surveillance and control for catheter-related bloodstream infections (CRBI) was priority in detection and risk assessment an infectious complication of puncture catheterization that substantially justified with inclusion of two main components as an addition to the existing system: monitoring of puncture catheterization, which allows to obtain and analyze data on risk factors for infections associated with the catheterization procedure and subsequent manipulations of the device, standardize approaches to working with a venous catheter and improve the diagnosis of CRBI; assessment of ensuring the epidemiological safety of medical care for catheterized patients. Epidemiological efficiency risk-based surveillance, primarily determined to reduce the incidence of CRBI by 1.8 times compared to initially defined real incidence: 12.5‰ (95% CI — CI 11,8–13 2) vs 22.8‰ (95% CI 21,1–24,5) catheterized patients, p=0.0001.
- Open Access
- 10 July 2020
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 98 (6) , 7-14-14
Prediction of lethal outcomes in COVID-19 cases based on the results chest computed tomography
The objective: to predict lethal outcomes in patients with COVID-19 based on the result of chest computed tomography (chest CT) using a semi-quantitative visual scale of the pulmonary parenchyma lesion.Subjects and methods. Inclusion criteria: patients who underwent chest CT from March 2 to May 1, 2020, inclusively, upon referral of a general practitioner due to suspected community-acquired pneumonia caused by COVID-19. Chest CT was performed in 48 medical organizations providing primary medical care to the adult population in Moscow. Exclusion criteria: patients whose chest CT was not assessed by CT 0-4 score; patients who were not confirmed as COVID-19 positive.In the Russian Federation, CT 0-4 score is recommended to be used for assessment of the extent of lung parenchyma lesion in cases with suspected COVID-19.Data on fatal outcomes were received on May 4, 2020 inclusive.Results: data of 13,003 patients from the Unified Radiological Information Service were retrospectively included in the study according to inclusion and exclusion criteria. The test aimed to detect a trend of directional changes in the proportion of deceased patients among various categories using CT 0-4 score demonstrated a statistically significant result (p < 0.0001). The chance of a lethal outcome increases directionally from CT-0 to CT-4. The test for deviations from the linear trend also provided p < 0.0001, i.e. when moving to higher scores (CT-3 and CT-4), there was an accelerated increase in the risk of death. Analysis of overall survival using the Cox regression model showed that the assessed factors (age and CT 0-4 score) were statistically significantly associated with the time to death from COVID-19 (p < 0.05). The risk of death increased with age, on average, 8.6% for every 5 years (95% CI 0.8-17.0%). When transferring from one category of CT to the next one, the risk increased by 38% on the average (95% CI 17.1-62.6%). There was no statistically significant association of gender factor with overall survival (p = 0.408).The visual score of CT 0-4 recommended for use in the Russian Federation to assess lung parenchyma lesions according to chest CT data, is a predictor of a lethal outcome in patients with COVID-19. CT 0-4 score is convenient for practical use.
- 10 July 2020
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 98 (6) , 7-14-14
Open AccessPrediction of lethal outcomes in COVID-19 cases based on the results chest computed tomography
The objective: to predict lethal outcomes in patients with COVID-19 based on the result of chest computed tomography (chest CT) using a semi-quantitative visual scale of the pulmonary parenchyma lesion.Subjects and methods. Inclusion criteria: patients who underwent chest CT from March 2 to May 1, 2020, inclusively, upon referral of a general practitioner due to suspected community-acquired pneumonia caused by COVID-19. Chest CT was performed in 48 medical organizations providing primary medical care to the adult population in Moscow. Exclusion criteria: patients whose chest CT was not assessed by CT 0-4 score; patients who were not confirmed as COVID-19 positive.In the Russian Federation, CT 0-4 score is recommended to be used for assessment of the extent of lung parenchyma lesion in cases with suspected COVID-19.Data on fatal outcomes were received on May 4, 2020 inclusive.Results: data of 13,003 patients from the Unified Radiological Information Service were retrospectively included in the study according to inclusion and exclusion criteria. The test aimed to detect a trend of directional changes in the proportion of deceased patients among various categories using CT 0-4 score demonstrated a statistically significant result (p < 0.0001). The chance of a lethal outcome increases directionally from CT-0 to CT-4. The test for deviations from the linear trend also provided p < 0.0001, i.e. when moving to higher scores (CT-3 and CT-4), there was an accelerated increase in the risk of death. Analysis of overall survival using the Cox regression model showed that the assessed factors (age and CT 0-4 score) were statistically significantly associated with the time to death from COVID-19 (p < 0.05). The risk of death increased with age, on average, 8.6% for every 5 years (95% CI 0.8-17.0%). When transferring from one category of CT to the next one, the risk increased by 38% on the average (95% CI 17.1-62.6%). There was no statistically significant association of gender factor with overall survival (p = 0.408).The visual score of CT 0-4 recommended for use in the Russian Federation to assess lung parenchyma lesions according to chest CT data, is a predictor of a lethal outcome in patients with COVID-19. CT 0-4 score is convenient for practical use.
- Open Access
- 10 June 2020
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 17 (2) , 95-102
Primary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow
Background. The number of people infected with SARS-CoV-2 causing COVID-19 is growing worldwide. It is necessary to study features of prevalence and clinical signs in pediatric population considering the fact that this disease is rather new.The aim of the study is to analyze the features of prevalence and clinical signs of pathologic process of COVID-19 in pediatric patients according to the results of practical experience of primary care medical facility (Children’s City Outpatients Clinic № 133) under the conditions of pandemia.Methods. Pediatricians of Children’s City Outpatient’s Clinic № 133 have examined certain categories of pediatric patients (especially who came from abroad or contacted with infection) for the presence of a new coronaviral infection in February 2020. Doctors have been examining children with catarrhal symptoms and hyperthermia since March 2020. The survey of children in February and March was carried out in accordance with algorithms (uniform for adults and children) approved by the Moscow City Health Department. Later, the survey was carried out in accordance with the guidelines for children prepared by the Ministry of Health of the Russian Federation. The throat and nose swabs on SARS-CoV-2 were performed for all patients on the 1st, 11th and 13th day of the disease.Results. 1,900 children (or 3.1% of total attached pediatric population) have been examined in our outpatient’s clinic with the polymerase chain reaction (PCR) method on the presence of the new coronavirus RNA since the beginning of the COVID-19 pandemic in Russia. The course of disease was analyzed in first 100 patients with the confirmed COVID-19 diagnosis: 58 (58%) boys and 42 (42%) girls. In 81% of cases we revealed the source of infection, in 19% – we did not. The disease was asymptomatic in 11 (11%) children examined after the contact with ill relatives; 89% had mild COVID-19 disease with light catarrhal signs. The most numerous group of patients who had COVID-19 consisted of children over 10 years of age (42%); in 20% of cases it was pupils from 7 to 10 years old. Smell disorders were reported in children over the age of 10 in 50% of all cases.Conclusion. New coronaviral infection COVID-19 in children is taking mild course, without complications, under the «mask» of common viral infection. Thus, it is unknown either those who have undergone COVID-19 asymptomatically remain healthy or they need special rehabilitation. The timely development of clear algorithm with step-by-step instructions for various situations for every health professional is crucial during these difficult times.
- 10 June 2020
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 17 (2) , 95-102
Open AccessPrimary Observational Results on Children Who Have Been Exposed to COVID-19 in Moscow
Background. The number of people infected with SARS-CoV-2 causing COVID-19 is growing worldwide. It is necessary to study features of prevalence and clinical signs in pediatric population considering the fact that this disease is rather new.The aim of the study is to analyze the features of prevalence and clinical signs of pathologic process of COVID-19 in pediatric patients according to the results of practical experience of primary care medical facility (Children’s City Outpatients Clinic № 133) under the conditions of pandemia.Methods. Pediatricians of Children’s City Outpatient’s Clinic № 133 have examined certain categories of pediatric patients (especially who came from abroad or contacted with infection) for the presence of a new coronaviral infection in February 2020. Doctors have been examining children with catarrhal symptoms and hyperthermia since March 2020. The survey of children in February and March was carried out in accordance with algorithms (uniform for adults and children) approved by the Moscow City Health Department. Later, the survey was carried out in accordance with the guidelines for children prepared by the Ministry of Health of the Russian Federation. The throat and nose swabs on SARS-CoV-2 were performed for all patients on the 1st, 11th and 13th day of the disease.Results. 1,900 children (or 3.1% of total attached pediatric population) have been examined in our outpatient’s clinic with the polymerase chain reaction (PCR) method on the presence of the new coronavirus RNA since the beginning of the COVID-19 pandemic in Russia. The course of disease was analyzed in first 100 patients with the confirmed COVID-19 diagnosis: 58 (58%) boys and 42 (42%) girls. In 81% of cases we revealed the source of infection, in 19% – we did not. The disease was asymptomatic in 11 (11%) children examined after the contact with ill relatives; 89% had mild COVID-19 disease with light catarrhal signs. The most numerous group of patients who had COVID-19 consisted of children over 10 years of age (42%); in 20% of cases it was pupils from 7 to 10 years old. Smell disorders were reported in children over the age of 10 in 50% of all cases.Conclusion. New coronaviral infection COVID-19 in children is taking mild course, without complications, under the «mask» of common viral infection. Thus, it is unknown either those who have undergone COVID-19 asymptomatically remain healthy or they need special rehabilitation. The timely development of clear algorithm with step-by-step instructions for various situations for every health professional is crucial during these difficult times.